Investors Writing for Investors
Results 1 - 10 of 260 : 1 2 3 4 5 6 7 8 9 Next
A Step Closer to Quadrific Sales
Gilead's Quad easily gets past the FDA advisory panel.
1 Biotech With 2 Binary Events in 2 Days
Two of Gilead's HIV drugs head in front of FDA advisory committee meetings.
Will Gilead Sciences Help You Retire Rich?
Stocks that give retirees what they want are incredibly valuable.
Maybe There Will Be Some Hep C Patients Left
Sales of Vertex's Incivek decline substantially.
Celebrate the Hep C Wins, for Now
Good data in small packages.
2 Biotechs Absolutely Crushing It
Human Genome Sciences' takeover and Gilead's hep-C drug rock.
Why the Hepatitis C Sector Popped and Dropped
Is this meaningful or just another movement?
Health Care Reform: Potential Winners and Losers
A trinary event in the making.
2 Positive Signs for Gilead Sciences
These two metrics can tell you a lot.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK